Medications

Hadlima

Hadlima

Previously Found with Medfinder

Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.

Estimated Insurance Pricing
$0–$50 copay with commercial insurance; prior authorization typically required, and many plans prefer biosimilars over Humira.
Estimated Cash Pricing
$1,000–$1,500 per injection at retail; Organon offers a $0 co-pay savings card for eligible commercially insured patients.
Medfinder Findability Score
40
/100
Summarize this guide with AI:

Post Author

Peter Daggett

Last Updated

February 24, 2026

Hadlima 2026 Availability, Prices, and Tips to Find

What Is Hadlima?

Hadlima (adalimumab-bwwd) is an FDA-approved biosimilar to Humira manufactured by Organon. It belongs to the class of TNF (tumor necrosis factor) blockers — biologic medications that target inflammation at its source. Hadlima is approved to treat a wide range of autoimmune and inflammatory conditions, including:

  • Moderately to severely active rheumatoid arthritis in adults
  • Psoriatic arthritis in adults
  • Ankylosing spondylitis in adults
  • Moderately to severely active Crohn's disease in adults and children 6+
  • Moderately to severely active ulcerative colitis in adults
  • Moderate to severe plaque psoriasis in adults
  • Moderate to severe hidradenitis suppurativa in adults
  • Juvenile idiopathic arthritis in patients 2+
  • Non-infectious uveitis in adults

As a biosimilar, Hadlima has been shown to be highly similar to the reference product Humira with no clinically meaningful differences in safety, purity, or effectiveness.

How does Hadlima work?

Hadlima is a fully human monoclonal antibody that works by binding specifically to tumor necrosis factor-alpha (TNF-alpha), a protein in the body that drives inflammation. In autoimmune conditions, the immune system overproduces TNF-alpha, leading to chronic inflammation and tissue damage. By blocking TNF-alpha from attaching to cell surface receptors, Hadlima helps reduce inflammation, ease symptoms like joint pain and swelling, and slow disease progression. The medication is administered via subcutaneous injection, typically every other week, though some conditions require higher loading doses initially.

What doses are available for Hadlima?

  • 40 mg/0.8 mL prefilled syringe
  • 40 mg/0.8 mL prefilled autoinjector (Hadlima PushTouch)
  • 40 mg/0.4 mL prefilled syringe (citrate-free, less painful injection)
  • 40 mg/0.4 mL prefilled autoinjector (Hadlima PushTouch, citrate-free)
  • 40 mg/0.8 mL single-dose vial (institutional use only)

The 40 mg/0.4 mL citrate-free formulations are generally preferred by patients as they cause less injection site pain.

How hard is it to find Hadlima in stock?

Hadlima scores a 40 out of 100 on our findability scale, meaning it can be difficult to locate at many pharmacies. As a newer adalimumab biosimilar that launched in July 2023, not all pharmacies routinely stock it. Many retail pharmacies still default to dispensing Humira, and formulary transitions are ongoing. Specialty pharmacies and mail-order services tend to have better availability. If your local pharmacy doesn't carry Hadlima, Medfinder can help you locate a pharmacy that has it in stock near you.

The #1 Medication Locating Service

Find {drug} in-stock near you

Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.

25K+
Trusted by 25,000+ Happy Patients

Who Can Prescribe Hadlima?

Hadlima is most commonly prescribed by specialists who manage autoimmune and inflammatory diseases:

  • Rheumatologists — for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
  • Gastroenterologists — for Crohn's disease and ulcerative colitis
  • Dermatologists — for plaque psoriasis and hidradenitis suppurativa
  • Ophthalmologists — for non-infectious uveitis
  • Internal Medicine physicians may also prescribe it in some cases

Because Hadlima requires prior authorization from most insurance plans and carries a boxed warning, it is almost always initiated by a specialist rather than a primary care physician.

Is Hadlima a controlled substance?

No, Hadlima is not a controlled substance and is not scheduled by the DEA. It is a prescription biologic medication that requires a valid prescription from a licensed healthcare provider but does not have the prescribing restrictions associated with controlled substances.

Common Side Effects of Hadlima

  • Upper respiratory infections (cold, sinus infections)
  • Injection site reactions — redness, pain, or swelling at the injection site
  • Headache
  • Rash
  • Nausea
  • Back pain
  • Urinary tract infections

Important: Hadlima carries a boxed warning for serious infections (including tuberculosis and invasive fungal infections) and an increased risk of lymphoma and other malignancies, particularly in children and adolescents. TB testing is required before starting treatment. Contact your doctor immediately if you develop fever, persistent cough, or signs of infection while taking Hadlima.

Alternative Medications to Hadlima

If you're unable to find Hadlima or it's not right for you, several alternatives are available:

  • Humira (adalimumab) — the original reference biologic product
  • Amjevita (adalimumab-atto) — adalimumab biosimilar by Amgen
  • Hyrimoz (adalimumab-adaz) — adalimumab biosimilar by Sandoz
  • Cyltezo (adalimumab-adbm) — an interchangeable adalimumab biosimilar by Boehringer Ingelheim

All of these treat the same conditions and work through the same TNF-blocking mechanism. Your doctor and insurance plan will help determine which option provides the best balance of cost and availability for you. Use Medfinder to check availability of any of these alternatives.

Drug Interactions with Hadlima

  • Abatacept (Orencia) — increased risk of serious infections; avoid concurrent use
  • Anakinra (Kineret) — increased risk of serious infections; avoid concurrent use
  • Live vaccines — should not be given during Hadlima treatment due to immunosuppression
  • Other biologic DMARDs — combining biologics increases immunosuppression risk
  • Azathioprine and 6-Mercaptopurine — increased risk of hepatosplenic T-cell lymphoma when combined with TNF blockers

Methotrexate is commonly used alongside Hadlima for rheumatoid arthritis and is generally considered safe in combination, though it may affect how the body clears adalimumab. Always inform your doctor of all medications you are taking.

Final Thoughts on Hadlima

Hadlima offers patients a significantly more affordable biosimilar alternative to Humira, with a wholesale acquisition cost of roughly $1,038 per carton compared to Humira's $6,922. However, because it's a relatively new biosimilar, finding it stocked at your local pharmacy can be challenging — many pharmacies still default to Humira or other more established options. Specialty pharmacies and mail-order services often have better Hadlima availability. If your insurance plan covers Hadlima (and many now prefer biosimilars), Organon's $0 co-pay card can bring your out-of-pocket cost down substantially. Use Medfinder to locate Hadlima in stock near you and save time calling pharmacies.

Learn more about {drug}

No items found.

25,000+ have already found their meds with Medfinder.

Start your search today.
99% success rate
Fast-turnaround time
Never call another pharmacy